Clinical trial
IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4
NCT06703567 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4
- Lead sponsor
- European Institute of Oncology
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 6, 2024
- Completion date
- December 31, 2025
- Enrollment
- 82 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer